Akari Therapeutics, Plc (AKTX) Stock Price

0.6156 ▼ -0.0699 (-10.20%)
Open: 0.65 Vol: 149.04K Day's range: 0.60 - 0.6847 Nov 06, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AKTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.67▼ 0.68▼ 0.68▼ 0.72▼ 0.77▼
MA10 0.69▼ 0.67▼ 0.67▼ 0.74▼ 0.81▼
MA20 0.68▼ 0.71▼ 0.71▼ 0.78▼ 0.93▼
MA50 0.72▼ 0.74▼ 0.74▼ 0.84▼ 1.08▼
MA100 0.74▼ 0.79▼ 0.82▼ 0.95▼ 1.82▼
MA200 0.86▼ 0.84▼ 0.88▼ 1.08▼ 7.08▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.003▼ -0.005▼ -0.010▼ -0.008▼
RSI 38.167▼ 40.658▼ 40.811▼ 35.227▼ 32.302▼
STOCH 17.612▼ 23.946     17.151▼ 30.651     32.286    
WILL %R -100.000▼ -98.294▼ -98.294▼ -93.500▼ -93.389▼
CCI -96.948     -68.866     -75.364     -265.339▼ -118.169▼
Latest Filters Detected On AKTX
▼ GAP $AKTX Open Gap Down %5 Set Alert
▼ GAP $AKTX Open Gap Down %3 Set Alert
▼ GAP $AKTX Open Gap Down %2 Set Alert
▼ BREAK $AKTX Price Breaks 30 Days Low Set Alert
▼ BREAK $AKTX Price Breaks 20 Days Low Set Alert
▼ BREAK $AKTX Price Breaks 10 Days Low Set Alert
Akari Therapeutics, Plc News
Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Wednesday, November 05, 2025 01:09 AM
SMX (Security Matters) Public Limited Company (NASDAQ: SMX) gained 70% to $2.50 in pre-market trading after SMX and CARTIF entered into non-binding LOI to integrate SMX’s end-to-end tracing platform ...
Akari Therapeutics’ Accepted Abstract Showcasing its Novel Splicing-Targeted ADC Payload Driving Immune Activation Now Available
Tuesday, November 04, 2025 06:36 AM
Utilizing its innovative ADC payload platform, Akari is advancing a new class of immuno-oncology ADCs built on the platform of a novel PH1 payload, a spliceosome modulator that has a unique ...
Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP
Thursday, October 30, 2025 05:45 AM
BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced ...
AKTX historical stock data
date open high low close volume
06/11/25 0.65 0.6847 0.60 0.6156 149,037
05/11/25 0.69 0.7499 0.635 0.6855 417,890
04/11/25 0.7799 0.84 0.7209 0.82 5,175,623
03/11/25 0.7609 0.77 0.7164 0.725 20,190
31/10/25 0.731 0.76 0.70 0.75 95,289
30/10/25 0.7595 0.7595 0.7299 0.7303 188,906
29/10/25 0.787 0.80 0.7464 0.7505 79,210
28/10/25 0.7874 0.83 0.75 0.7713 158,392
27/10/25 0.75 0.7999 0.74 0.7943 206,599
24/10/25 0.7389 0.7649 0.7314 0.74 82,330
Quote Details
52wk Low:0.571
52wk High:2.45
Vol:149.04K
Avg Vol(3m):6.1M
1Y Chng:-58.12%
1M Chng:-36.54%
Add to Watch List
More Information
Index US Composite
Market Cap. 22.36M